Opko Health Inc (OPK)

Tel Aviv
Currency in ILS
457.9
+6.8(+1.51%)
Delayed Data·
OPK Scorecard
Full Analysis
Management has been aggressively buying back shares
OPK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
451.1461.8
52 wk Range
442.0734.4
Key Statistics
Edit
Bid/Ask
458.00 / 458.10
Prev. Close
451.1
Open
451.1
Day's Range
451.1-461.8
52 wk Range
442-734.4
Volume
213.91K
Average Volume (3m)
454.85K
1-Year Change
-2.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OPK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Opko Health Inc News & Analysis

Show more

Opko Health Inc Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, immunology, and infectious diseases; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins or peptides; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products for a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Spain, Ireland, Chile, and Mexico. OPKO Health, Inc. was founded in 2007 and is headquartered in Miami, Florida.

Employees
2997
Market
Israel

Compare OPK to Peers and Sector

Metrics to compare
OPK
Peers
Sector
Relationship
P/E Ratio
−26.2x−15.0x−0.5x
PEG Ratio
−0.310.000.00
Price/Book
0.8x0.5x2.6x
Price / LTM Sales
1.5x1.6x3.0x
Upside (Analyst Target)
-41.2%51.5%
Fair Value Upside
Unlock29.7%9.4%Unlock

Earnings

Latest Release
May 01, 2025
EPS / Forecast
-0.10 / --
Revenue / Forecast
149.95M / --
EPS Revisions
Last 90 days

OPK Income Statement

FAQ

What Is the Opko Health Inc (OPK) Stock Price Today?

The Opko Health Inc stock price today is 457.90

What Stock Exchange Does Opko Health Inc Trade On?

Opko Health Inc is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Opko Health Inc?

The stock symbol for Opko Health Inc is "OPK."

What Is the Opko Health Inc Market Cap?

As of today, Opko Health Inc market cap is 3.56B.

What Is Opko Health Inc's Earnings Per Share (TTM)?

The Opko Health Inc EPS (TTM) is -0.06.

From a Technical Analysis Perspective, Is OPK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Opko Health Inc Stock Split?

Opko Health Inc has split 0 times.

How Many Employees Does Opko Health Inc Have?

Opko Health Inc has 2997 employees.

What is the current trading status of Opko Health Inc (OPK)?

As of 19 Jun 2025, Opko Health Inc (OPK) is trading at a price of 457.90, with a previous close of 451.10. The stock has fluctuated within a day range of 451.10 to 461.80, while its 52-week range spans from 442.00 to 734.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.